EPS for Jiangsu Hengrui Medicine (600276.SS)

EPS in 2025 (TTM): S$0.17

According to Jiangsu Hengrui Medicine 's latest financial reports the company's current EPS (TTM) is S$0.17. In 2024 the company made an earnings per share (EPS) of S$0.18 an increase over its 2023 EPS that were of S$0.12.

EPS history for Jiangsu Hengrui Medicine from 2000 to 2025

Annual EPS

Year	EPS	Change
2025 (TTM)	S$0.17	-3.12%
2024	S$0.18	42.43%
2023	S$0.12	8.77%
2022	S$0.11	-20.62%
2021	S$0.14	-26.59%
2020	S$0.20	27.24%
2019	S$0.15	28.41%
2018	S$0.12	20.04%
2017	S$0.10	31.21%
2016	S$0.07647	11.46%
2015	S$0.06861	36.27%
2014	S$0.05035	19.77%
2013	S$0.04204	18.05%
2012	S$0.03561	23.9%
2011	S$0.02874	26.9%
2010	S$0.02265	12.37%
2009	S$0.02016	56.6%
2008	S$0.01287	9.18%
2007	S$0.01179	114.48%
2006	S$0.005497	64.83%
2005	S$0.003335	35.55%
2004	S$0.002460	29.73%
2003	S$0.001896	19.86%
2002	S$0.001582	-2.71%
2001	S$0.001626	1.02%
2000	S$0.001610

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions